Medicinova (MNOV) Stock: Buy, Sell, or Hold?
$1.40
-0.01 (-0.71%)
âŧ
5d:
-3.45%
30d:
-4.76%
90d:
+6.87%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
53/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.38 â $1.55
Position: SLIGHTLY LOW
Forward P/E & Valuation
-2.7x
Next 12M consensus est.
Wall Street Target
$8.25
+489.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.38 / $1.55
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: MNOV is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When MNOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MNOV is currently trading at $1.40, which is considered slightly low relative to its 30-day fair value range of $1.38 to $1.55.
Technical Outlook: Technically, MNOV is showing sideways momentum. The price is currently testing key support at $1.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.25 (+489.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MNOV is showing sideways momentum. The price is currently testing key support at $1.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.25 (+489.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.38 -
$1.55
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$1.38 -
$1.55
Current vs Trading Range
SLIGHTLY LOW
Support Level
$1.38
Resistance Level
$1.55
Current Trend
Sideways
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 489.3% below Wall St target ($8.25)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.72
Wall Street Target
$8.25
(+489.3%)
Revenue Growth (YoY)
240.6%
Share MNOV Analysis
Share this live MNOV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MNOV)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Sep 30, 2026
Daily AI digest
AI Retail Discussion Summary:
All patients have completed the blinded portion of $MNOV's Phase 2b/3 MN-166 study for COMBAT-ALS, and the company has moved into database lock and analysis.
Key Retail Themes:
Clinical trial progress
ALS treatment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 1:05 AM ET
Data refreshes hourly during market hours. Next update: 2:05 AM
Data refreshes hourly during market hours. Next update: 2:05 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
ABVX
Abivax SA American DeposâĻ |
STRONG BUY
12 analysts |
$164 | 64 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MNOV Research Pages
